These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4138250)

  • 1. Letter: L.A.T.S. and Graves' disease.
    Volpé R; Farid NR; Von Westarp C; Row VV
    Lancet; 1974 Oct; 2(7884):843. PubMed ID: 4138250
    [No Abstract]   [Full Text] [Related]  

  • 2. Ophthalmic Graves' disease. Diagnosis and pathogenesis.
    Hall R; Kirkham K; Doniach D; el-Kabir D
    Lancet; 1970 Feb; 1(7643):375-8. PubMed ID: 4189686
    [No Abstract]   [Full Text] [Related]  

  • 3. Humoral immunity in Graves' disease.
    McKenzie JM; Zakarija M; Sato A
    Clin Endocrinol Metab; 1978 Mar; 7(1):31-45. PubMed ID: 580600
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).
    Volpé R; Desbarats-Schonbaum ML; Schonbaum E; Row VV; Ezrin C
    Am J Med; 1969 Feb; 46(2):217-26. PubMed ID: 5818477
    [No Abstract]   [Full Text] [Related]  

  • 5. Evolution of the concept of the pathogenesis of toxic diffuse goitre (Graves' disease) and an assessment of the long-acting thyroid stimulator (L.A.T.S.).
    Hassan HA
    J Egypt Med Assoc; 1978; 61(1-2):111-20. PubMed ID: 583050
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: Thyroid-stimulating immunoglobulins.
    Hedley AJ
    Lancet; 1975 Apr; 1(7912):918. PubMed ID: 47560
    [No Abstract]   [Full Text] [Related]  

  • 7. [LATS-the extrapituitary thyroid stimulator and its role in the etiology and pathogenesis of Graves-Basedow disease].
    Nauman J; Nauman A
    Pol Arch Med Wewn; 1969 Oct; 43(4):1427-32. PubMed ID: 5395131
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma LATS and thyroid antibody level, and the clinical manifestations of Graves' disease.
    Földes J; Takó J; Bános C; Gesztesi E; Varga I
    Acta Med Acad Sci Hung; 1969; 26(3):233-43. PubMed ID: 5395883
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship between the long-acting thyroid stimulator and the thyroid microsomal antibody.
    Bonnyns M; Vanhaelst L
    J Endocrinol; 1969 Jan; 43(1):125-6. PubMed ID: 4886576
    [No Abstract]   [Full Text] [Related]  

  • 10. Graves' ophthalmopathy following external neck irradiation for nonthyroidal neoplastic disease.
    Wasnich RD; Grumet FC; Payne RO; Kriss JP
    J Clin Endocrinol Metab; 1973 Nov; 37(5):703-13. PubMed ID: 4800434
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial: The latest of L.A.T.S.
    Lancet; 1974 Aug; 2(7878):443-4. PubMed ID: 4136681
    [No Abstract]   [Full Text] [Related]  

  • 12. Pathogenesis of neonatal Graves' disease.
    McKenzie JM; Zakarija M
    J Endocrinol Invest; 1978 Apr; 1(2):183-9. PubMed ID: 385703
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-acting thyroid stimulator in Graves' disease.
    Sellers EA; Awad AG; Schönbaum E
    Lancet; 1970 Aug; 2(7668):335-8. PubMed ID: 4194442
    [No Abstract]   [Full Text] [Related]  

  • 14. LATS in Graves' disease.
    McKenzie JM; Zakarija M
    Recent Prog Horm Res; 1976; 33():29-57. PubMed ID: 198858
    [No Abstract]   [Full Text] [Related]  

  • 15. Thyroid-stimulating immunoglobulins in Graves' disease.
    Smith BR; Hall R
    Lancet; 1974 Aug; 2(7878):427-31. PubMed ID: 4137321
    [No Abstract]   [Full Text] [Related]  

  • 16. LATS and Graves' disease.
    Soloman DH; Chopra IJ
    Calif Med; 1970 Aug; 113(2):50-5. PubMed ID: 5538194
    [No Abstract]   [Full Text] [Related]  

  • 17. Radioimmunological studies on the long-acting thyroid stimulator.
    Pinchera A; Rovis L; Grasso L; Liberti P; Martino E; Fenzi GF; Baschieri L
    Endocrinology; 1970 Aug; 87(2):217-25. PubMed ID: 4193237
    [No Abstract]   [Full Text] [Related]  

  • 18. Observations against a causal relationship between the long-acting thyroid stimulator and ophthalmopathy in Graves' disease.
    McKenzie JM; McCullagh EP
    J Clin Endocrinol Metab; 1968 Aug; 28(8):1177-82. PubMed ID: 4175472
    [No Abstract]   [Full Text] [Related]  

  • 19. The long-acting thyroid stimulatory: is it of importance in Graves' disease.
    McKenzie JM; Zakarija M; D'Amour P; Joasoo A
    N Z Med J; 1975 Jan; 81(531):18-21. PubMed ID: 165442
    [No Abstract]   [Full Text] [Related]  

  • 20. Graves' disease--1972.
    Solomon DH; Chopra IJ
    Mayo Clin Proc; 1972 Nov; 47(11):803-13. PubMed ID: 4678498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.